NAS:ARNA (USA) Also trade in: Germany UK

Arena Pharmaceuticals Inc

$ 53.5 0 (0%)
Volume: 642,674 Avg Vol (1m): 519,624
Market Cap $: 2.65 Bil Enterprise Value $: 1.60 Bil
P/E (TTM): 4.41 P/B: 2.20
Earnings Power Value -147.49
Net Current Asset Value 20.28
Tangible Book 24.26
Projected FCF 30.19
Median P/S Value 419.19
Graham Number 81.27
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
YTD (-%)
49.57
(Mil)
Shares Outstanding
81.02%
57.37 (Mil)
Institutional Ownership
5.27%
2.59 (Mil)
Insider Ownership
99.86%
49.5 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Arena Pharmaceuticals Inc. Peter Lynch prefers to buy companies with low institutional ownership.

Insider ownership (%)

This is the historical insider ownership of Arena Pharmaceuticals Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

Top Fund Holders